Angiotensin-converting enzyme inhibitors: past, present, and bright future

Lancet. 1985 Jan 5;1(8419):30-4. doi: 10.1016/s0140-6736(85)90975-4.
No abstract available

Publication types

  • Review

MeSH terms

  • Angiotensin II / blood
  • Angiotensin-Converting Enzyme Inhibitors*
  • Animals
  • Antihypertensive Agents / therapeutic use*
  • Captopril / adverse effects
  • Captopril / pharmacology
  • Captopril / therapeutic use*
  • Dipeptides / adverse effects
  • Dipeptides / pharmacology
  • Dipeptides / therapeutic use*
  • Drug Eruptions / etiology
  • Drug Interactions
  • Enalapril
  • Heart Failure / drug therapy
  • Humans
  • Hyperaldosteronism / drug therapy
  • Hypertension / drug therapy
  • Hypertension, Renal / drug therapy
  • Kidney Diseases / chemically induced
  • Neutropenia / chemically induced
  • Proline / analogs & derivatives*
  • Taste Disorders / chemically induced

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Dipeptides
  • Angiotensin II
  • Enalapril
  • Proline
  • Captopril